Fact CheckerSign in

NCT04287218Completed

Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors

A Randomized Controlled Trial Comparing the Efficacy of Therapist Guided Internet-delivered Cognitive Therapy (TG-iConquerFear) With Augmented Treatment as Usual in Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

Cognitive therapy has been shown to reduce fear of cancer recurrence (FCR), mainly in breast cancer survivors. The accessibility of cognitive behavioural interventions could be further improved by Internet delivery, but self-guided interventions have shown limited efficacy. The aim of this study is to test the efficacy of a therapist guided internet-delivered intervention (TG-iConquerFear) vs. augmented treatment as usual (aTAU) in Danish colorectal cancer survivors.

Status (registry)
Completed
Study type
Interventional
Enrollment
95 (actual)
First submitted
25 Feb 2020
Start date
10 May 2023
Primary completion date
1 Jul 2024
Lead sponsor
Vejle Hospital
NCT number
NCT04287218

What you commit to

  • Study type: Interventional
  • Participants enrolled: 95
  • From 10 May 2023 to the primary completion date, 1 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cancer recurrence at any follow-up
  • Inability to comply with the protocol due to severe psychiatric, cognitive disorder or substance abuse identified during telephone interview

Other

  • As the intervention is web-based, participants without knowledge of or access to the Internet will be excluded from the RCT (including dyslexia).

Who the study is looking for

  • Completed curative intent colorectal cancer treatment with surgery and/or radiation and/or adjuvant chemotherapy between 1 March 2014 and 31 December 2018
  • No history of recurrence after primary operation
  • Fear of Cancer Recurrence Inventory score of 22 or above (14)
  • Age 18 or above
  • Reads and understands Danish
  • Access and ability to use Internet

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vejle Hospital, University Hospital of Southern Denmark
Coordinator of this site? Confirm its status
VejleDenmarkUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.